[Diagnosis of tumors with the use of immunologic tumor markers].
D000951:Antigens, Neoplasm / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis; D006801:Humans; D007165:Immunosuppression Therapy; D008113:Liver Neoplasms / Q000175:diagnosis; D008297:Male; D009363:Neoplasm Proteins / Q000032:analysis*; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D009369:Neoplasms / Q000032:analysis / Q000175:diagnosis* / Q000276:immunology; D010190:Pancreatic Neoplasms / Q000175:diagnosis; D010455:Peptides / Q000032:analysis; D012397:Rosette Formation; D013601:T-Lymphocytes / Q000276:immunology; D013736:Testicular Neoplasms / Q000175:diagnosis; D019396:Tissue Polypeptide Antigen; D000509:alpha-Fetoproteins / Q000032:analysis; D001613:beta 2-Microglobulin / Q000032:analysis
D000951:Antigens, Neoplasm; D002272:Carcinoembryonic Antigen; D009363:Neoplasm Proteins; D010455:Peptides; D019396:Tissue Polypeptide Antigen; D000509:alpha-Fetoproteins; D001613:beta 2-Microglobulin
Tumordiagnostik unter Verwendung immunologischer Tumor-Marker.